MXCT vs UPST · rev $38.6M vs P/E 74, rev $636.5M
MaxCyte Inc (MXCT) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported UPST revenue for 2024-12-31 was $636.5M. Net income was -$128.6M. Revenue was up 23.9% from 2023-12-31 to 2024-12-31. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
MXCT currently screens at market cap $124.3M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the MXCT and UPST stock pages for the full models.
Not investment advice.